Gilead Sciences Inc (GILD)
90.20
+0.36
(+0.40%)
USD |
NASDAQ |
Nov 05, 16:00
90.39
+0.19
(+0.21%)
After-Hours: 20:00
Gilead Sciences Max Drawdown (5Y): 41.71% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 41.71% |
| September 30, 2024 | 41.71% |
| August 31, 2024 | 41.71% |
| July 31, 2024 | 43.12% |
| June 30, 2024 | 43.18% |
| May 31, 2024 | 43.18% |
| April 30, 2024 | 43.18% |
| March 31, 2024 | 43.18% |
| February 29, 2024 | 43.67% |
| January 31, 2024 | 44.02% |
| December 31, 2023 | 44.02% |
| November 30, 2023 | 44.02% |
| October 31, 2023 | 44.02% |
| September 30, 2023 | 45.75% |
| August 31, 2023 | 45.75% |
| July 31, 2023 | 45.75% |
| June 30, 2023 | 45.75% |
| May 31, 2023 | 45.75% |
| April 30, 2023 | 45.75% |
| March 31, 2023 | 45.75% |
| February 28, 2023 | 45.75% |
| January 31, 2023 | 45.75% |
| December 31, 2022 | 45.75% |
| November 30, 2022 | 45.75% |
| October 31, 2022 | 45.75% |
| Date | Value |
|---|---|
| September 30, 2022 | 45.75% |
| August 31, 2022 | 45.75% |
| July 31, 2022 | 45.75% |
| June 30, 2022 | 45.75% |
| May 31, 2022 | 45.75% |
| April 30, 2022 | 45.75% |
| March 31, 2022 | 45.75% |
| February 28, 2022 | 45.75% |
| January 31, 2022 | 45.75% |
| December 31, 2021 | 45.75% |
| November 30, 2021 | 45.75% |
| October 31, 2021 | 45.75% |
| September 30, 2021 | 45.75% |
| August 31, 2021 | 45.75% |
| July 31, 2021 | 45.75% |
| June 30, 2021 | 45.75% |
| May 31, 2021 | 45.75% |
| April 30, 2021 | 45.75% |
| March 31, 2021 | 45.75% |
| February 28, 2021 | 45.75% |
| January 31, 2021 | 45.75% |
| December 31, 2020 | 45.75% |
| November 30, 2020 | 45.75% |
| October 31, 2020 | 45.75% |
| September 30, 2020 | 45.75% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
41.71%
Minimum
Aug 2024
45.75%
Maximum
Nov 2019
45.18%
Average
45.75%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Merck & Co Inc | 27.26% |
| Eli Lilly and Co | 22.48% |
| Amgen Inc | 24.86% |
| Pfizer Inc | 54.78% |
| Bristol-Myers Squibb Co | 47.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 6.737 |
| Beta (5Y) | 0.1742 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 23.43% |
| Historical Sharpe Ratio (5Y) | 0.3836 |
| Historical Sortino (5Y) | 0.726 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 9.18% |